In a report released today, Andreas Argyrides from Wedbush reiterated a Buy rating on United Therapeutics (UTHR – Research Report), with a price target of $305.00. The company’s shares closed yesterday at $243.75.
According to TipRanks, Argyrides is a 4-star analyst with an average return of 14.6% and a 49.30% success rate. Argyrides covers the Healthcare sector, focusing on stocks such as Ascendis Pharma, Verona Pharma, and Immunic.
In addition to Wedbush, United Therapeutics also received a Buy from J.P. Morgan’s Jessica Fye in a report issued today. However, yesterday, Bank of America Securities maintained a Sell rating on United Therapeutics (NASDAQ: UTHR).
See today’s best-performing stocks on TipRanks >>
Based on United Therapeutics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $516 million and a net profit of $239.3 million. In comparison, last year the company earned a revenue of $444.7 million and had a net profit of $162.7 million
Based on the recent corporate insider activity of 132 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UTHR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Read More on UTHR:
